Latest News

Testing Parkinson's disease immune-based drugs: New models

Using powerful, newly developed cell culture and mouse models of sporadic Parkinson?s disease (PD), researchers have demonstrated that immunotherapy with specifically targeted antibodies may block the development and spread of PD pathology in the brain. By intercepting the distorted and misfolded alpha-synuclein (?-syn) proteins that enter and propagate in neurons, creating aggregates, the researchers prevented the development of pathology and also reversed some of the effects of already-existing disease.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • With racial segregation declining between neighborhoods, segregation now taking new form

  • Gene variants modifying Huntington's symptom onset may lead to new therapeutic strategies

  • Prescription for medical students: A day at the art museum?

  • Aquariums deliver health and wellbeing benefits

  • Teaching med students about health disparities builds their confidence

  • Antibiotics increase risk of hearing loss in patients with deadly bacterial infections

  • Changing clocks, changing seasons: Scientists find role for neuronal plasticity

  • Genetic tug of war in the brain influences parental control over offspring behavior

  • Generally accepted tools used to select patients for aneurysm treatment in need of further evaluation

  • Analysis of post deployment health assessment forms indicates risks of alcohol abuse among service members returning from deployment

  •